Role of survivin and its splice variants in tumorigenesis
Open Access
- 21 December 2004
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 92 (2), 212-216
- https://doi.org/10.1038/sj.bjc.6602340
Abstract
Survivin, a unique member of the inhibitor of apoptosis (IAP) protein family, is highly expressed in cancer but is undetectable in nonproliferating normal adult tissues, suggesting a potential role in tumorigenesis. Differential splicing of survivin pre-mRNA results in three new survivin variants, survivin-DeltaEx3, survivin-2B, and survivin-3B. Loss of survivin-2B expression was found in the later stage of cancer development, while survivin and survivin-DeltaEx3 are not, suggesting a differential role of them in tumour development. In this minireview, the author intends to summarise and discuss the current data relevant to the role of survivin and its splicing variants in tumorigenesis, which may facilitate further investigation in this interesting area.Keywords
This publication has 39 references indexed in Scilit:
- An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapyOncogene, 2004
- An Anti-Wnt-2 Monoclonal Antibody Induces Apoptosis in Malignant Melanoma Cells and Inhibits Tumor GrowthCancer Research, 2004
- HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?Oral Oncology, 2004
- The Chemopreventive Agent Sulindac Attenuates Expression of the Antiapoptotic Protein Survivin in Colorectal Carcinoma CellsJournal of Pharmacology and Experimental Therapeutics, 2003
- Strategic Attack on Host Cell Gene Expression during Adenovirus InfectionJournal of Virology, 2003
- Survivin study: What is the next wave?Journal of Cellular Physiology, 2003
- Differential subcellular localization of functionally divergent survivin splice variantsCell Death & Differentiation, 2002
- Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomasInternational Journal of Cancer, 2002
- Immunohistochemical Localization of Survivin in Benign Cervical Mucosa, Cervical Dysplasia, and Invasive Squamous Cell CarcinomaAmerican Journal of Clinical Pathology, 2002
- Expression of Survivin in HTLV-I-Infected T-Cell Lines and Primary ATL CellsBiochemical and Biophysical Research Communications, 2001